Journals / The Anatolian Journal of Cardiology / 2015 / Cilt: 15 - Sayı: 10

Rheumatoid factor mediates excess serum lipoprotein(a) for independent association with type 2 diabetes in men

Pages
782–788
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

RF-positive subjects were not significantly associated independently with hypertension.Conclusion: Autoimmune activation linked to Lp(a) is mediated by the autoantibody RF in contributing to the development of type 2 diabetes (Anatol J Cardiol 2015; 15: 782-8)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The potential association of rheumatoid factor (RF) and lipoprotein (Lp)(a) levels, as well as with the likelihood of type 2 diabetes and hypertension, needs exploring.
📊
Key Findings & Data:Methods: Cross-sectional associations were sought in this unselected and population-based 1539-adult cohort (age 58.8±10.6 years).
💡
Conclusion & Impact:RF-positive subjects were not significantly associated independently with hypertension.Conclusion: Autoimmune activation linked to Lp(a) is mediated by the autoantibody RF in contributing to the development of type 2 diabetes (Anatol J Cardiol 2015; 15: 782-8)
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The potential association of rheumatoid factor (RF) and lipoprotein (Lp)(a) levels, as well as with the likelihood of type 2 diabetes and hypertension, needs exploring. Methods: Cross-sectional associations were sought in this unselected and population-based 1539-adult cohort (age 58.8±10.6 years). RF was assayed nephelometrically. Multiple logistic regression analyses were used for covariates of RF positivity and for the latter's association with diabetes and hypertension. Results: RF-positive individuals were older, fewer current smokers, had significantly lower fasting triglycerides (by 13%), higher fibrinogen, and tended to higher sex hormone-binding globulin (SHBG) levels. Whereas, women had a similar risk profile irrespective of RF status, RF-positive men had significantly higher Lp(a). In contrast to Lp(a) being positively correlated with SHBG in RF-negative subjects (r=0.08; p=0.007), an inverse correlation existed in seropositive individuals (r=-0.32, p=0.011), suggesting the interplay of an immune complex. In regression analyses, RF positivity was associated with Lp(a) in men but not in women, [OR 1.53 (1.19; 1.96)], independent of age, SHBG, and C-reactive protein (CRP). RF positivity was further associated with diabetes [OR 1.98 (95% CI 1.11; 3.52)] in the whole sample, additively to waist circumference and CRP, major determinants of diabetes. RF-positive subjects were not significantly associated independently with hypertension.Conclusion: Autoimmune activation linked to Lp(a) is mediated by the autoantibody RF in contributing to the development of type 2 diabetes (Anatol J Cardiol 2015; 15: 782-8)

🔖

Cite This Article

ONAT, A., ADEMOĞLU, E., CAN, G., ALTAY, S., KARAGÖZ, A., KÖROĞLU, B., YÜKSEL, H. (2015). Rheumatoid factor mediates excess serum lipoprotein(a) for independent association with type 2 diabetes in men. The Anatolian Journal of Cardiology, Cilt: 15 - Sayı: 10, 782–788. https://ajindex.com/articles/365882

References (3)

  1. Lipsky PE. Rheumatoid arthritis. Chapter 285 in: Harrison's Principles of Internal Medicine, Vol 2, 13th edit. Isselbacher KJ, Braunwald E, Wilson JD, et al (Eds). McGraw-Hill, Inc., New York, 1994.p.1648-55
  2. Farheen K, Agarwal SK. Assessment of disease activity and treat- ment outcomes in rheumatoid arthritis. J Manag Care Pharm 2011; 17: S9-S13
  3. Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheu- matic drugs in rheumatoid arthritis. Arthritis Rheum 2008; 59: 762- 84. [CrossRef] 4. Boffa MB, Marcovina SM, Koschinsky ML. Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models. Clin Biochem 2004; 37: 333-43. [CrossRef] 5. The Emerging Risk Factors Collaboration, Erqou S, Kaptoge S, Perry PL, Di Angelantonio E, Thompson A, White IR, et al. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke and nonvascular mortality. JAMA 2009; 302: 412-23. [CrossRef] 6. Onat A, Hergenç G, Özhan H, Kaya Z, Bulur S, Ayhan E, et al. Lipoprotein(a) is associated with coronary heart disease in women independent of metabolic syndrome. Coron Artery Dis 2008; 19: 125-31. [CrossRef] 7. Onat A, Can G. Enhanced proinflammatory state and autoimmune activation: a breakthrough to understanding chronic diseases. Curr Pharm Des 2014; 20: 575-84. [CrossRef] 8. Bennet A, Di Angelantonio E, Erqou S, Eiriksdottir G, Sigurdsson G, Woodward M, et al. Lipoprotein(a) levels and risk of future coro- nary heart disease: large-scale prospective data. Arch Intern Med 2008; 168: 598-608. [CrossRef] 9. Werba JP, Safa O, Gianfranceschi G, Michelagnoli S, Sirtori CR, Franceschini G. Plasma triglycerides and lipoprotein(a): inverse relationship in a hyperlipidemic Italian population. Atherosclerosis 1993; 101: 203-11. [CrossRef] 10. Tsimikas S, Brilakis ES, Miller ER, McConnell JP, Lennon RJ, Kornman KS, et al. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med 2005; 353: 46-57. [CrossRef] 11. Nordestgaard BG, Chapman MJ, Ray K, Borén J, Andreotti F, Watts GF, et al. European Atherosclerosis Society Consensus Panel. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J 2010; 31: 2844-53. [CrossRef] 12. Onat A, Direskeneli H. Excess cardiovascular risk in inflammatory rheumatic diseases: pathophysiology and targeted therapy. Curr Ph